Mycobacteria as immunogens: Development of expression vectors for use in multiple mycobacterial species

Medical Principles and Practice

Volumn 6, Issue 2, 1997, Pages 91-96

  Gaora, Peadar Ó ^a   Barnini, Simona ^c   Hayward, Chris ^b   Filley, Elaine ^b   Rook, Graham ^b   Young, Douglas ^a   Thole, Jelle ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Expression vectors; Hygromycin selection; Mycobacteria; Mycobacterium vaccae; SIVp27; Vibrio harveyi luxAB

Indexed keywords

EID: 0002998894     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000157432     Document Type: Article

References (11)

1. Stover CK. Bansal GP. Hanson MS, Burlcin JE. Palaszynski SR, Young JF, Koenig S. Young DB, Sadziene A, Barbour AG: Protective immunity elicited by recombinant bacille Calmcttc-Guérin (BCG) expressing outer surface protein A (OspA) lipoprotein: A candidate Lyme disease vaccine. J Exp Med 1993; 178:197-209.
2. Langermann S. Palaszynski SR. Burlein JE. Koenig S, Hanson MS. Briles DE, Stover CK: Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmettc-Gué-rin vaccines expressing pneumococcal surface protein A. J Exp Med 1994:180:2277-2286.
3. Murray PJ. Aldovini A, Young RA: Manipulation and potentiation of antimycobacteria! immunity using recombinant bacille Calmette-Gué-rin strains that secrete cytokines. Proc Natl Acad Sei USA 1996:93: 934-939.
4. Weltman AC. Rose DN: The safety of bacille Calmcttc-Guérin vaccination in HIV infection and AIDS (editorial). AIDS 1993;7:149-157.
5. Garbe TR. Barathi J. Barnini S. Zhang Y. Abou-Zeid C, Tang D. Mukhcrjee R. Young DB: Transformation of mycobacterial species using hvgromycin as selectable marker. Microbiology 1994; 140:133-138.
6. Stanford JL. Rook GA. Bahr GM. Dowlati Y, Ganpati R. Ghazi Saidi K, Lucas S. Ramu G. Torres P. Ho Minh Ly H. Ansted N: Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. Vaccine 1990:8:525-530.
7. Andrew PW, Roberts IS: Construction of a bioluminescent mycobacterium and its use for assay of anti-mycobacterial agents. J Clin Microbiol 1993;31:2251-2254.
8. Almond N. Page M. Mills K. Jenkins A. Ling C. Thorpe R. Kitchin P, Williams M: The production and purification of PCR-dcrived recombinant simian immunodeficiency virus p27 gag protein: Its use in detecting serological and T-cell responses in macaques (erratum in J Virol Methods 1990:30:229). J Virol Methods 1990;28:321-326.
9. Maggi E. Parronchi P. Manctti R. Simonclli C, Piccinni MP. Rugiu FS, De Carli M. Ricci M. Romag-nani S: Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Thl and Th2 clones. J Immunol 1992: 148:2142-2147.
10. Hill PJ. Rees CE. Winson MK. Stewart GS: The application of lux genes. Biotechno! Appl Biochcm 1993;17:3-14.
11. Hickey MJ, Arain TM, Shawar RM, Humble DJ. Langhome MH, Mo-renroth JN, Stover CK: Lucifase in vivo expression technology: Use of recombinant mycobacterial reporter strains to evaluate antimycobacter-ial activity in mice. Antimicrob Agents Chcmother 1996:40:400-407.